272 related articles for article (PubMed ID: 22560549)
1. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
[TBL] [Abstract][Full Text] [Related]
2. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
[TBL] [Abstract][Full Text] [Related]
3. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose.
Thomas C; Di Maio S; Ma R; Vollans E; Chu C; Clark B; Lee R; McKenzie M; Martin M; Toyota B
J Neurosurg; 2007 Nov; 107(5):917-26. PubMed ID: 17977261
[TBL] [Abstract][Full Text] [Related]
4. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
5. Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion.
Kim YH; Kim DG; Han JH; Chung HT; Kim IK; Song SW; Park JH; Kim JW; Kim YH; Park CK; Kim CY; Paek SH; Jung HW
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):61-7. PubMed ID: 22580122
[TBL] [Abstract][Full Text] [Related]
6. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
7. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
8. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
[TBL] [Abstract][Full Text] [Related]
9. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing.
Hasegawa T; Kida Y; Kato T; Iizuka H; Yamamoto T
J Neurosurg; 2011 Dec; 115(6):1078-86. PubMed ID: 21961962
[TBL] [Abstract][Full Text] [Related]
11. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
[TBL] [Abstract][Full Text] [Related]
12. Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts.
Andrews DW; Werner-Wasik M; Den RB; Paek SH; Downes-Phillips B; Willcox TO; Bednarz G; Maltenfort M; Evans JJ; Curran WJ
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):419-26. PubMed ID: 19042095
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience.
Aoyama H; Onodera S; Takeichi N; Onimaru R; Terasaka S; Sawamura Y; Shirato H
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):329-34. PubMed ID: 22704983
[TBL] [Abstract][Full Text] [Related]
14. Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation.
Champ CE; Shen X; Shi W; Mayekar SU; Chapman K; Werner-Wasik M; Farrell CJ; Gunn V; Downes MB; Liu H; Evans JJ; Andrews DW
Neurosurgery; 2013 Sep; 73(3):489-96. PubMed ID: 23756743
[TBL] [Abstract][Full Text] [Related]
15. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
[TBL] [Abstract][Full Text] [Related]
16. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
17. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for vestibular schwannomas.
Mulder JJ; Kaanders JH; van Overbeeke JJ; Cremers CW
Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):367-71. PubMed ID: 22931906
[TBL] [Abstract][Full Text] [Related]
19. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
[TBL] [Abstract][Full Text] [Related]
20. Fractionated stereotactic radiation therapy for vestibular schwannomas: Dosimetric factors predictive of hearing outcomes.
Bennion NR; Nowak RK; Lyden ER; Thompson RB; Li S; Lin C
Pract Radiat Oncol; 2016; 6(5):e155-e162. PubMed ID: 26961715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
